Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2010

01.11.2010 | Article

HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster

verfasst von: J. Verbeeck, L. Kwanten, F. D’Heygere, A. Beguin, S. Michiels, I. Desombere, G. Leroux-Roels, P. Lemey, F. Nevens, M. Van Ranst

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

In order to study the hepatitis C virus (HCV) epidemiology in Flanders, Belgium, the HCV genotype of 2,301 patients diagnosed with HCV between 2001 and 2009 was determined. HCV genotyping was conducted using the Versant LiPA 1.0 or Versant LiPA 2.0 assay. To explore the transmission history of a remarkable cluster of the rarely found HCV genotype 5a, face-to-face interviews based on detailed questionnaires and maximum likelihood phylogenetic analysis were performed. HCV genotype 1 was the most prevalent genotype in all provinces, followed by HCV genotype 3 in East Flanders, Antwerp, Flemish Brabant and Limburg. In Brussels, HCV genotype 4 was the second most prevalent genotype. This observation is due to the immigration of patients from the Middle East and Africa. Remarkably, a cluster of HCV genotype 5a was found in West Flanders, where it represents the second most prevalent genotype, accounting for 26.2% of HCV infections. We could not identify one major transmission source explaining the whole HCV genotype 5a epidemic. Instead, several smaller possible transmission chains were identified and confirmed phylogenetically. Overall, the HCV genotype 5a epidemic in West Flanders seems to be mainly associated with blood transfusion and unsafe medical practices.
Literatur
1.
Zurück zum Zitat World Health Organization (WHO) (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6(1):35–47CrossRef World Health Organization (WHO) (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6(1):35–47CrossRef
2.
Zurück zum Zitat Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962–973CrossRefPubMed Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962–973CrossRefPubMed
3.
Zurück zum Zitat Cristina J (2005) Genetic diversity and evolution of hepatitis C virus in the Latin American region. J Clin Virol 34(Suppl 2):S1–S7CrossRefPubMed Cristina J (2005) Genetic diversity and evolution of hepatitis C virus in the Latin American region. J Clin Virol 34(Suppl 2):S1–S7CrossRefPubMed
4.
Zurück zum Zitat Pawlotsky JM (2003) Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 7(1):45–66CrossRefPubMed Pawlotsky JM (2003) Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 7(1):45–66CrossRefPubMed
5.
Zurück zum Zitat Chamberlain RW, Adams NJ, Taylor LA, Simmonds P, Elliott RM (1997) The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236(1):44–49CrossRefPubMed Chamberlain RW, Adams NJ, Taylor LA, Simmonds P, Elliott RM (1997) The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236(1):44–49CrossRefPubMed
6.
Zurück zum Zitat Beutels M, Van Damme P, Aelvoet W, Desmyter J, Dondeyne F, Goilav C, Mak R, Muylle L, Pierard D, Stroobant A, Van Loock F, Waumans P, Vranckx R (1997) Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol 13(3):275–280CrossRefPubMed Beutels M, Van Damme P, Aelvoet W, Desmyter J, Dondeyne F, Goilav C, Mak R, Muylle L, Pierard D, Stroobant A, Van Loock F, Waumans P, Vranckx R (1997) Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol 13(3):275–280CrossRefPubMed
7.
Zurück zum Zitat Van Damme P, Thyssen A, Van Loock F (2002) Epidemiology of hepatitis C in Belgium: present and future. Acta Gastroenterol Belg 65(2):78–79PubMed Van Damme P, Thyssen A, Van Loock F (2002) Epidemiology of hepatitis C in Belgium: present and future. Acta Gastroenterol Belg 65(2):78–79PubMed
8.
Zurück zum Zitat Gérard C, Delwaide J, Vaira D, Bastens B, Servais B, Wain E, Bataille C, Daenen G, Belaïche J; GLEVHE (2005) Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. J Med Virol 76(4):503–510CrossRefPubMed Gérard C, Delwaide J, Vaira D, Bastens B, Servais B, Wain E, Bataille C, Daenen G, Belaïche J; GLEVHE (2005) Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. J Med Virol 76(4):503–510CrossRefPubMed
9.
Zurück zum Zitat Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M (2006) Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80(9):4220–4226CrossRefPubMed Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M (2006) Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80(9):4220–4226CrossRefPubMed
10.
Zurück zum Zitat Higgins DG, Sharp PM (1988) CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73(1):237–244CrossRefPubMed Higgins DG, Sharp PM (1988) CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73(1):237–244CrossRefPubMed
11.
Zurück zum Zitat Swofford DL (2002) PAUP*: Phylogenetic Analysis Using Parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, MA Swofford DL (2002) PAUP*: Phylogenetic Analysis Using Parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, MA
12.
Zurück zum Zitat Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14(9):817–818CrossRefPubMed Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14(9):817–818CrossRefPubMed
13.
Zurück zum Zitat Matheï C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F (2005) Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Eur J Clin Microbiol Infect Dis 24(8):514–522CrossRefPubMed Matheï C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F (2005) Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Eur J Clin Microbiol Infect Dis 24(8):514–522CrossRefPubMed
14.
Zurück zum Zitat Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, Hoffman P, Hemmer R, Staub T, Seguin-Devaux C, Schmit JC (2008) Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol 14(8):1237–1243CrossRefPubMed Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, Hoffman P, Hemmer R, Staub T, Seguin-Devaux C, Schmit JC (2008) Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol 14(8):1237–1243CrossRefPubMed
15.
Zurück zum Zitat Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L (2008) Changing HCV genotypes distribution in Poland—relation to source and time of infection. J Clin Virol 42(2):156–159CrossRefPubMed Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L (2008) Changing HCV genotypes distribution in Poland—relation to source and time of infection. J Clin Virol 42(2):156–159CrossRefPubMed
16.
Zurück zum Zitat Bourlière M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustière C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9(1):62–70CrossRefPubMed Bourlière M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustière C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9(1):62–70CrossRefPubMed
17.
Zurück zum Zitat Christofidou M, Lambropoulou-Karatza C, Dimitracopoulos G, Spiliopoulou I (2000) Distribution of hepatitis C virus genotypes in viremic patients with beta-thalassemia. Eur J Clin Microbiol Infect Dis 19(9):728–730CrossRefPubMed Christofidou M, Lambropoulou-Karatza C, Dimitracopoulos G, Spiliopoulou I (2000) Distribution of hepatitis C virus genotypes in viremic patients with beta-thalassemia. Eur J Clin Microbiol Infect Dis 19(9):728–730CrossRefPubMed
18.
Zurück zum Zitat Kleter B, Brouwer JT, Nevens F, van Doorn LJ, Elewaut A, Versieck J, Michielsen PP, Hautekeete ML, Chamuleau RA, Brénard R, Bourgeois N, Adler M, Quint WG, Bronkhorst CM, Heijtink RA, Hop WJ, Fevery J, Schalm SW (1998) Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver 18(1):32–38PubMed Kleter B, Brouwer JT, Nevens F, van Doorn LJ, Elewaut A, Versieck J, Michielsen PP, Hautekeete ML, Chamuleau RA, Brénard R, Bourgeois N, Adler M, Quint WG, Bronkhorst CM, Heijtink RA, Hop WJ, Fevery J, Schalm SW (1998) Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver 18(1):32–38PubMed
19.
Zurück zum Zitat Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Müllhaupt B, Borovicka J, Heim M, Moradpour D, Cerny A, Malinverni R, Francioli P, Negro F; Swiss Hepatitis C Cohort Study Group (2009) Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol 51(4):655–666CrossRefPubMed Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Müllhaupt B, Borovicka J, Heim M, Moradpour D, Cerny A, Malinverni R, Francioli P, Negro F; Swiss Hepatitis C Cohort Study Group (2009) Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol 51(4):655–666CrossRefPubMed
20.
Zurück zum Zitat Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78:321–328PubMed Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78:321–328PubMed
21.
Zurück zum Zitat Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182(3):698–707CrossRefPubMed Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182(3):698–707CrossRefPubMed
22.
Zurück zum Zitat Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G (2005) Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76(3):327–332CrossRefPubMed Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G (2005) Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76(3):327–332CrossRefPubMed
23.
Zurück zum Zitat Delwaide J, Reenaers C, Gérard C, Vaira D, Bastens B, Servais B, Bekhti A, Bataille C, Wain E, De Leeuw P, Daenen G, Mesureur T, Sente JM, Belaïche J; Groupe Liégeois d’Etude des Virus Hépatotropes (2006) HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. Eur J Gastroenterol Hepatol 18(7):707–712CrossRefPubMed Delwaide J, Reenaers C, Gérard C, Vaira D, Bastens B, Servais B, Bekhti A, Bataille C, Wain E, De Leeuw P, Daenen G, Mesureur T, Sente JM, Belaïche J; Groupe Liégeois d’Etude des Virus Hépatotropes (2006) HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. Eur J Gastroenterol Hepatol 18(7):707–712CrossRefPubMed
24.
Zurück zum Zitat Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourlière M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F (2005) Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: the GEMHEP GenoCII Study. J Viral Hepat 12(4):405–413CrossRefPubMed Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourlière M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F (2005) Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: the GEMHEP GenoCII Study. J Viral Hepat 12(4):405–413CrossRefPubMed
25.
Zurück zum Zitat Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH (2002) Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance. J Clin Microbiol 40(5):1866–1868CrossRefPubMed Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH (2002) Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance. J Clin Microbiol 40(5):1866–1868CrossRefPubMed
26.
Zurück zum Zitat van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S; European and Italian Seroconverter Studies (2004) Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189(2):292–302CrossRefPubMed van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S; European and Italian Seroconverter Studies (2004) Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189(2):292–302CrossRefPubMed
27.
Zurück zum Zitat van de Laar TJ, Langendam MW, Bruisten SM, Welp EA, Verhaest I, van Ameijden EJ, Coutinho RA, Prins M (2005) Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. J Med Virol 77(4):509–518CrossRefPubMed van de Laar TJ, Langendam MW, Bruisten SM, Welp EA, Verhaest I, van Ameijden EJ, Coutinho RA, Prins M (2005) Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. J Med Virol 77(4):509–518CrossRefPubMed
28.
Zurück zum Zitat de Bruijne J, Schinkel J, Prins M, Koekkoek SM, Aronson SJ, van Ballegooijen MW, Reesink HW, Molenkamp R, van de Laar TJ (2009) Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol 47(12):3832–3838CrossRefPubMed de Bruijne J, Schinkel J, Prins M, Koekkoek SM, Aronson SJ, van Ballegooijen MW, Reesink HW, Molenkamp R, van de Laar TJ (2009) Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol 47(12):3832–3838CrossRefPubMed
29.
Zurück zum Zitat De Maeght S, Henrion J, Bourgeois N, de Galocsy C, Langlet P, Michielsen P, Reynaert H, Robaeys G, Sprengers D, Orlent H, Adler M (2008) A pilot observational survey of hepatitis C in Belgium. Acta Gastroenterol Belg 71(1):4–8PubMed De Maeght S, Henrion J, Bourgeois N, de Galocsy C, Langlet P, Michielsen P, Reynaert H, Robaeys G, Sprengers D, Orlent H, Adler M (2008) A pilot observational survey of hepatitis C in Belgium. Acta Gastroenterol Belg 71(1):4–8PubMed
30.
Zurück zum Zitat Abergel A, Ughetto S, Dubost S, Bonny C, Aublet-Cuvelier B, Delarocque-Astagneau E, Bailly JL, Bommelaer G, Casanova S, Delteil J, Deny P, Laurichesse H, Odent-Malaure H, Roussel J, Peigue-Lafeuille H, Henquell C (2007) The epidemiology and virology of hepatitis C virus genotype 5 in central France. Aliment Pharmacol Ther 26(10):1437–1446CrossRefPubMed Abergel A, Ughetto S, Dubost S, Bonny C, Aublet-Cuvelier B, Delarocque-Astagneau E, Bailly JL, Bommelaer G, Casanova S, Delteil J, Deny P, Laurichesse H, Odent-Malaure H, Roussel J, Peigue-Lafeuille H, Henquell C (2007) The epidemiology and virology of hepatitis C virus genotype 5 in central France. Aliment Pharmacol Ther 26(10):1437–1446CrossRefPubMed
31.
Zurück zum Zitat Antaki N, Haddad M, Kebbewar K, Abdelwahab J, Hamed O, Aaraj R, Alhaj N, Haffar S, Assil M, Ftayeh M, Assaad F, Doghman D, Ali T, Nasserelddine M, Ali A, Antaki F; Syrian Working Group for the Study of Viral Hepatitis (2009) The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province. Epidemiol Infect 137(1):79–84CrossRefPubMed Antaki N, Haddad M, Kebbewar K, Abdelwahab J, Hamed O, Aaraj R, Alhaj N, Haffar S, Assil M, Ftayeh M, Assaad F, Doghman D, Ali T, Nasserelddine M, Ali A, Antaki F; Syrian Working Group for the Study of Viral Hepatitis (2009) The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province. Epidemiol Infect 137(1):79–84CrossRefPubMed
32.
Zurück zum Zitat Jover R, Pérez-Serra J, de Vera F, Alamo JM, Muñoz C, Yago C, Martínez-Ramírez R, Vidal JV (2001) Infection by genotype 5a of HCV in a district of southeast Spain. Am J Gastroenterol 96(10):3042–3043CrossRefPubMed Jover R, Pérez-Serra J, de Vera F, Alamo JM, Muñoz C, Yago C, Martínez-Ramírez R, Vidal JV (2001) Infection by genotype 5a of HCV in a district of southeast Spain. Am J Gastroenterol 96(10):3042–3043CrossRefPubMed
Metadaten
Titel
HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster
verfasst von
J. Verbeeck
L. Kwanten
F. D’Heygere
A. Beguin
S. Michiels
I. Desombere
G. Leroux-Roels
P. Lemey
F. Nevens
M. Van Ranst
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1021-0

Weitere Artikel der Ausgabe 11/2010

European Journal of Clinical Microbiology & Infectious Diseases 11/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.